Education
About Us
Working with TipRanks
Follow Us
OS Therapies Incorporated (OSTX)
:OSTX
OSTX Stock Chart & Stats
$1.83
$0.51(10.41%)
At close: 4:00 PM EST
$1.83
$0.51(10.41%)
Day’s Range― - ―
52-Week Range$1.12 - $7.00
Previous CloseN/A
Volume28.07K
Average Volume (3M)375.03K
Market Cap
$54.23M
Enterprise Value$61.83M
Total Cash (Recent Filing)$1.88M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.16
Next Earnings
Apr 06, 2026EPS Estimate
-0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding35,214,350
10 Day Avg. Volume630,713
30 Day Avg. Volume375,033
Financial Highlights & Ratios
PEG Ratio-0.30
Price to Book (P/B)-17.05
Price to Sales (P/S)0.00
P/FCF Ratio-12.27
Enterprise Value/Market Cap1.14
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-258.12
Enterprise Value/Ebitda-3.43
Forecast
1Y Price Target
$11.50Price Target Upside528.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Clinical Trial ResultsThe recent positive updated data from the Phase 2b trial evaluating OST-HER2 in recurrent osteosarcoma showed improved 12-month event-free survival.
Market OpportunityOS Therapies' OST-HER2 holds FDA Orphan, Fast Track, and Rare Pediatric Disease designations, making it eligible for a priority review voucher, which represents a significant opportunity for non-dilutive capital.
Regulatory ApprovalThe completion of a successful Type C meeting with the FDA supports the accelerated approval pathway for OS Therapies' Phase 2b OST-HER2 program.
Bears Say
OS Therapies Incorporated News
OSTX FAQ
What was OS Therapies Incorporated’s price range in the past 12 months?
OS Therapies Incorporated lowest stock price was $1.12 and its highest was $7.00 in the past 12 months.
What is OS Therapies Incorporated’s market cap?
OS Therapies Incorporated’s market cap is $54.23M.
When is OS Therapies Incorporated’s upcoming earnings report date?
OS Therapies Incorporated’s upcoming earnings report date is Apr 06, 2026 which is in 104 days.
How were OS Therapies Incorporated’s earnings last quarter?
OS Therapies Incorporated released its earnings results on Nov 14, 2025. The company reported -$0.21 earnings per share for the quarter, missing the consensus estimate of -$0.122 by -$0.088.
Is OS Therapies Incorporated overvalued?
According to Wall Street analysts OS Therapies Incorporated’s price is currently Undervalued.
Does OS Therapies Incorporated pay dividends?
OS Therapies Incorporated does not currently pay dividends.
What is OS Therapies Incorporated’s EPS estimate?
OS Therapies Incorporated’s EPS estimate is -0.14.
How many shares outstanding does OS Therapies Incorporated have?
OS Therapies Incorporated has 35,214,350 shares outstanding.
What happened to OS Therapies Incorporated’s price movement after its last earnings report?
OS Therapies Incorporated reported an EPS of -$0.21 in its last earnings report, missing expectations of -$0.122. Following the earnings report the stock price went down -1.099%.
Which hedge fund is a major shareholder of OS Therapies Incorporated?
Currently, no hedge funds are holding shares in OSTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
OS Therapies Incorporated Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.50 (528.42% Upside)
$11.50 (528.42% Upside)
Blogger Sentiment
Bullish
OSTX Sentiment 70%
Sector Average ―
Sector Average ―
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 6.5%
Last 30 Days ▼ 6.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-60.61%
12-Months-Change
Fundamentals
Return on Equity
-914.04%
Trailing 12-Months
Asset Growth
352.81%
Trailing 12-Months
Company Description
OS Therapies Incorporated
OS Therapies Incorporated (OSTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of cancer and other serious diseases. The company operates within the healthcare sector, with a strong emphasis on oncology research and development. Its core products and services include the creation of targeted therapies designed to improve patient outcomes and quality of life through advanced scientific approaches.
OSTX Stock 12 Month Forecast
Average Price Target
$11.50
▲(528.42% Upside)
Technical Analysis
Actinium Pharmaceuticals
―
Adverum Biotechnologies
―
Annovis Bio
―
Gain Therapeutics
―
Klotho Neurosciences
―
Ownership Overview
14.89% Insiders
0.28% Mutual Funds
1.68% Other Institutional Investors
81.89% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---